[Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer for patients (2024 edition)].

Lung cancer, a malignant tumor remaining high incidence and mortality rates in China and globally, places huge burdens to families and the public healthcare system. In order to improve the diagnosis and treatment of lung cancer, enhance patients' knowledge of the disease, promote evidence-based guidelines to patients, and facilitate shared decision-making, the Chinese Medical Association convened multidisciplinary experts, patients, and public representatives to develop the Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer for patients. The guideline selected most concerned issues, drew on information from domestic and international guidelines, latest research findings, and clinical experience of lung cancer, and combined them with current clinical practices in China and patients' needs. This guideline aims to provide comprehensive, scientific, and practical information on lung cancer diagnosis and treatment for patients and their families, help them further understanding the basic knowledge, diagnosis and treatment process, treatment methods, and prognosis management of lung cancer, enhance the self-management ability of patients, and raise the public awareness and participation in lung cancer prevention and treatment.